Cellular immunity to β2-glycoprotein-1 in patients with the antiphospholipid syndrome

Journal of Immunology

Volumn 162, Issue 11, 1999, Pages 6919-6925

  Visvanathan, Sudha ^a   McNeil, H Patrick ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; BETA2 GLYCOPROTEIN 1; CARDIOLIPIN ANTIBODY; CD14 ANTIGEN; CD19 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; EPITOPE; GAMMA INTERFERON; IMMUNOGLOBULIN; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PHOSPHOLIPID BINDING PROTEIN; PROTHROMBIN;

ADULT; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; HELPER CELL; HUMAN; HUMAN CELL; IMMEDIATE TYPE HYPERSENSITIVITY; MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

ADULT; ANTIBODIES, ANTIPHOSPHOLIPID; ANTICOAGULANTS; ANTIGEN-PRESENTING CELLS; ANTIPHOSPHOLIPID SYNDROME; BETA 2-GLYCOPROTEIN I; CD4-POSITIVE T-LYMPHOCYTES; EPITOPES, T-LYMPHOCYTE; GLYCOPROTEINS; HUMANS; IMMUNITY, CELLULAR; INTERFERON TYPE II; INTERLEUKIN-4; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MIDDLE AGED; PHOSPHOLIPIDS;

EID: 0033152842     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Harris, E. N., J. K. Chan, R. A. Asherson, V. R. Aber, A. E. Gharavi, and G. R. Hughes. 1986. Thrombosis, recurrent fetal loss, and thrombocytopenia: predictive value of the anticardiolipin antibody test. Arch. Intern. Med. 146:2153.
2. 2-glycoprotein (apolipoprotein H). Proc. Natl. Acad. Sci. USA 87:4120.
3. Galli, M., P. Comfurius, C. Maassen, H. C. Hemker, B. M. de, B. Van, P. J. Vriesman, T. Barbui, R. F. Zwaal, and E. M. Bevers. 1990. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 335:1544.
4. Matsuura, E, Y. Igarashi, M. Fujimoto, K. Ichikawa, and T. Koike. 1990. Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet 336:177.
5. McNeil, H. P., C. N. Chesterman, and S. A. Krilis. 1991. Immunology and clinical importance of antiphospholipid antibodies. Adv. Immunol. 49:193.
6. 2-glycoprotein I complex is an antigen for anticardiolipin antibodies occurring in autoimmune disease but not with infection. Lupus 1:75.
7. 2-glycoprotein-I than with antiphospholipid antibodies. J. Rheumatol. 22:1899.
8. 2-glycoprotein I in the absence of phospholipid: importance of antigen density and bivalent binding. J. Immunol. 154: 954.
9. Roubey, R. A. 1996. Immunology of the antiphospholipid antibody syndrome. Arthritis Rheum. 39:1444.
10. 2-glycoprotein I antibody affinity. J. Immunol. 161:2038.
11. 2-glycoprotein I critical for lipid binding and anti-cardiolipin antibody cofactor activity. Proc. Natl Acad. Sci. USA 90:2141.
12. 2GPI. Proc. Natl. Acad. Sci. USA 95:15542.
13. 2GPI in antibody binding. J. Immunol. 160:3917.
14. 2-glycoprotein I: a plasma inhibitor of the contact activation of the intrinsic blood coagulation pathway. Blood 66:1086.
15. 2-glycoprotein-I (apo-H) inhibits the release reaction of human platelets during ADP-induced aggregation. Atherosclerosis 63:109.
16. 2-glycoprotein I is potentiated by a distinct subgroup of anticardiolipin antibodies. Thromb. Haemost. 68:297.
17. Blank, M., I. Krause, N. Lanir, P. Vardi, B. Gilburd, A. Tincani, Y. Tomer, and Y. Shoenfeld. 1995. Transfer of experimental antiphospholipid syndrome by bone marrow cell transplantation: the importance of the T cell. Arthritis Rheum. 38:115.
18. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
19. Ekong, T., E. Kupek, A. Hill, C. Clark, A. Davies, and A. Pinching. 1993. Technical influences on immunophenotyping by flow cytometry. J. Immunol. Methods 164:263.
20. +. Becton Dickinson Immunocytometry Systems, San Jose, p. 22-23.
21. Bevers, E. M., M. Galli, T. Barbui, P. Comfurius, and R. F. Zwaal. 1991. Lupus anticoagulant IgG's (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin. Thromb. Haemost. 66:629.
22. Khamashta, M. A., E. N. Harris, A. E. Gharavi, G. Derue, A. Gil, J. J. Vazquez, and G. R. Hughes. 1988. Immune-mediated mechanism for thrombosis: antiphospholipid antibody binding to platelet membranes. Ann. Rheum. Dis. 47:849.
23. 2-glycoprotein I. J. Clin. Invest. 90:1100.
24. Atkinson, M. A., D. L. Kaufman, L. Campbell, K. A. Gibbs, S. C. Shah, D. F. Bu, M. G. Erlander, A. J. Tobin, and N. K. Maclaren. 1992. Response of peripheral-blood mononuclear cells to glutamate decarboxylase in insulin-dependent diabetes. Lancet 339:458.
25. Baekkeskov, S., H. J. Aanstoot, S. Christgau, A. Reetz, M. Solimena, M. Cascalho, F. Folli, H. Richter-Olesen, P. DeCamilli, and P. DeCamilli. 1990. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. [Published erratum appears in 1990 Nature 347:782.] Nature 347:151.
26. DeAizpurua, H. J., M. C. Honeyman, and L. C. Harrison. 1992. A 64-kDa antigen/glutamic acid decarboxylase (GAD) in fetal pig pro-islets: co-precipitation with a 38-kDa protein and recognition by T cells in humans at risk for insulin-dependent diabetes. J. Autoimmun. 5:759.
27. + T cells to lymphoproliferation and autoantibody production in MRL-lpr/lpr mice. J. Exp. Med. 167:1713.
28. Sobel, E. S., P. L. Cohen, and R. A. Eisenberg. 1993. lpr T cells are necessary for autoantibody production in lpr mice. J. Immunol. 150:4160.
29. Sobel, E. S., V. N. Kakkanaiah, M. Kakkanaiah, R. L. Cheek, P. L. Cohen, and R. A. Eisenberg. 1994. T-B collaboration for autoantibody production in lpr mice is cognate and MHC-restricted. J. Immunol. 152:6011.
30. Harrison, L. C., M. C. Honeyman, H. J. DeAizpurua, R. S. Schmidli, P. G. Colman, B. D. Tait, and D. S. Cram. 1993. Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes. Lancet 341:1365.
31. 2-glycoprotein I-dependent manner. J. Immunol. 157:2201.
32. Manfredi, A. A., P. Rovere, G. Galati, S. Heltai, E. Bozzolo, L. Soldini, J. Davoust, G. Balestrieri, A. Tincani, and M. G. Sabbadini. 1998. Apoptotic cell clearance in systemic lupus erythematosus: opsonization by antiphospholipid antibodies. Arthritis Rheum. 41:205.
33. Wegmann, T. G., H. Lin, L. Guilbert, and T. R. Mosmann. 1993. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol. Today 14:353.
34. Haimovici, F., J. A. Hill, and D. J. Anderson. 1991. The effects of soluble products of activated lymphocytes and macrophages on blastocyst implantation events in vitro. Biol. Reprod. 44:69.
35. Suffys, P., R. Beyaert, F. Van Roy, and W. Fiers. 1989. TNF in combination with interferon-γ is cytotoxic to normal, untransformed mouse and rat embryo fibroblast-like cells. Anticancer Res. 9:167.
36. Yui, J., M. Garcia-Lloret, T. G. Wegmann, and L. J. Guilbert. 1994. Cytotoxicity of tumour necrosis factor-α and γ-interferon against primary human placental trophoblasts. Placenta 15:819.
37. Raghupathy, R. 1997. Th1-type immunity is incompatible with successful pregnancy. Immunol. Today 18:478.
38. Geczy, C. L. 1994. Cellular mechanisms for the activation of blood coagulation. Int. Rev. Cytol. 152:49.
39. Edwards, R. L., and F. R. Rickles. 1992. The role of leukocytes in the activation of blood coagulation. Semin. Hematol. 29:202.
40. Del Prete, G., M. De Carli, R. M. Lammel, M. M. D'Elios, K. C. Daniel, B. Giusti, R. Abbate, and S. Romagnani. 1995. Th1 and Th2 T-helper cells exert opposite regulatory effects on procoagulant activity and tissue factor production by human monocytes. Blood 86:250.
41. de Prost, D., V. Ollivier, C. Ternisien, and S. Chollet-Martin. 1990. Increased monocyte procoagulant activity independent of the lupus anticoagulant in patients with systemic lupus erythematosus. Thromb. Haemost. 64:216.
42. Schved, J. F., J. C. Gris, V. Ollivier, J. L. Wautier, G. Tobelem, and J. Caen. 1992. Procoagulant activity of endotoxin or tumor necrosis factor activated monocytes is enhanced by IgG from patients with lupus anticoagulant. Am. J. Hematol. 41:92.
43. Kornberg, A., M. Blank, S. Kaufman, and Y. Shoenfeld. 1994. Induction of tissue factor-like activity in monocytes by anti-cardiolipin antibodies. J. Immunol. 153: 1328.
44. Martini, F., A. Farsi, A. M. Gori, M. Boddi, S. Fedi, M. P. Domeneghetti, A. Passaleva, D. Prisco, and R. Abbate. 1996. Antiphospholipid antibodies (aPL) increase the potential monocyte procoagulant activity in patients with systemic lupus erythematosus Lupus 5:206.
45. Reverter, J. C., D. Tassies, J. Font, J. Monteagudo, G. Escolar, M. Ingelmo, and A. Ordinas. 1996. Hypercoagulable state in patients with antiphospholipid syndrome is related to high induced tissue factor expression on monocytes and to low free protein s. Arterioscler. Thromb. Vasc. Biol. 16:1319.
46. Cuadrado, M. J., C. Lopez-Pedrera, M. A. Khamashta, M. T. Camps, F. Tinahones, A. Torres, G. R. Hughes, and F. Velasco. 1997. Thrombosis in primary antiphospholipid syndrome: a pivotal role for monocyte tissue factor expression. Arthritis Rheum. 40:834.